| GO Type |
GO Category |
Enriched GO Terms |
p-Value |
Adjusted p-Value |
Enriched Genes |
| BP |
GO:0050896; response to stimulus
|
GO:0050728; negative regulation of inflammatory response |
5.250E-09 |
2.286E-05 |
FFAR4, NR1H4, PPARA, PPARD, PPARG |
| MF |
GO:0140110; transcription regulator activity
|
GO:0004879; nuclear receptor activity |
1.782E-08 |
4.311E-05 |
NR1H4, PPARA, PPARD, PPARG |
| MF |
GO:0060089; molecular transducer activity
|
GO:0003707; steroid hormone receptor activity |
3.815E-08 |
7.009E-05 |
NR1H4, PPARA, PPARD, PPARG |
| BP |
GO:0051179; localization
|
GO:0015908; fatty acid transport |
6.408E-08 |
9.966E-05 |
FABP3, PPARA, PPARD, PPARG |
| BP |
GO:0050896; response to stimulus
|
GO:0070542; response to fatty acid |
1.317E-07 |
1.593E-04 |
FABP3, FFAR1, NR1H4, PPARG |
| MF |
Unclassified;
|
GO:0004872; receptor activity |
6.394E-07 |
4.491E-04 |
FFAR1, FFAR4, GPBAR1, HPGD, NR1H4, PPARA, PPARD, PPARG |
| BP |
GO:0009987; cellular process
|
GO:0043401; steroid hormone mediated signaling pathway |
9.299E-07 |
5.956E-04 |
NR1H4, PPARA, PPARD, PPARG |
| BP |
GO:0009987; cellular process
|
GO:0038183; bile acid signaling pathway |
1.061E-06 |
6.418E-04 |
GPBAR1, NR1H4 |
| MF |
GO:0060089; molecular transducer activity
|
GO:0038181; bile acid receptor activity |
1.061E-06 |
6.418E-04 |
GPBAR1, NR1H4 |
| BP |
GO:0008152; metabolic process
|
GO:0006367; transcription initiation from RNA polymerase II promoter |
2.131E-06 |
1.160E-03 |
NR1H4, PPARA, PPARD, PPARG |
| BP |
GO:0009987; cellular process
|
GO:0030522; intracellular receptor signaling pathway |
3.045E-06 |
1.507E-03 |
NR1H4, PPARA, PPARD, PPARG |
| BP |
GO:0051179; localization
|
GO:0010891; negative regulation of sequestering of triglyceride |
3.534E-06 |
1.673E-03 |
PPARA, PPARG |
| BP |
GO:0051179; localization
|
GO:0010887; negative regulation of cholesterol storage |
5.300E-06 |
2.308E-03 |
PPARA, PPARG |
| BP |
GO:0008152; metabolic process
|
GO:0010871; negative regulation of receptor biosynthetic process |
5.300E-06 |
2.308E-03 |
PPARA, PPARG |
| BP |
GO:0008152; metabolic process
|
GO:2001300; lipoxin metabolic process |
5.300E-06 |
2.308E-03 |
ALOX15, HPGD |
| MF |
GO:0005488; binding
|
GO:0050543; icosatetraenoic acid binding |
5.300E-06 |
2.308E-03 |
FABP3, PPARG |
| BP |
GO:0023052; signaling
|
GO:0032024; positive regulation of insulin secretion |
8.974E-06 |
3.689E-03 |
FFAR1, NR1H4, PPARD |
| BP |
GO:0008152; metabolic process
|
GO:0071073; positive regulation of phospholipid biosynthetic process |
1.271E-05 |
4.941E-03 |
FABP3, NR1H4 |
| BP |
GO:0050896; response to stimulus
|
GO:0042060; wound healing |
1.306E-05 |
4.988E-03 |
ALOX15, PPARA, PPARD |
| MF |
GO:0060089; molecular transducer activity
|
GO:0004955; prostaglandin receptor activity |
1.588E-05 |
5.961E-03 |
HPGD, PPARG |
| BP |
GO:0008152; metabolic process
|
GO:1902894; negative regulation of pri-miRNA transcription from RNA polymerase II promoter |
1.940E-05 |
6.705E-03 |
PPARA, PPARD |
| BP |
GO:0051179; localization
|
GO:0060099; regulation of phagocytosis, engulfment |
1.940E-05 |
6.705E-03 |
ALOX15, PPARG |
| BP |
GO:0009987; cellular process
|
GO:0010745; negative regulation of macrophage derived foam cell differentiation |
2.749E-05 |
8.676E-03 |
PPARA, PPARG |
| BP |
GO:0050896; response to stimulus
|
GO:0009725; response to hormone |
2.975E-05 |
9.255E-03 |
FABP3, FFAR4, HPGD, PPARA, PPARG |
| BP |
GO:0008152; metabolic process
|
GO:0046321; positive regulation of fatty acid oxidation |
3.206E-05 |
9.697E-03 |
PPARA, PPARG |
| BP |
GO:0008152; metabolic process
|
GO:0032966; negative regulation of collagen biosynthetic process |
3.206E-05 |
9.697E-03 |
PPARD, PPARG |
